- Home
- Publications
- Publication Search
- Publication Details
Title
Update on psoriasis immunopathogenesis and targeted immunotherapy
Authors
Keywords
Psoriasis, Etanercept, Ustekinumab, Tofacitinib, Ruxolitinib
Journal
Seminars in Immunopathology
Volume 38, Issue 1, Pages 11-27
Publisher
Springer Nature
Online
2015-11-16
DOI
10.1007/s00281-015-0539-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Drugs and Treatment Targets in Psoriasis
- (2015) K Kofoed et al. ACTA DERMATO-VENEREOLOGICA
- Dermal γδ T cells – What have we learned?
- (2015) Rebecca L. O’Brien et al. CELLULAR IMMUNOLOGY
- Genetics of Psoriasis
- (2015) Satveer K. Mahil et al. DERMATOLOGIC CLINICS
- An Update on Topical Therapies for Mild-Moderate Psoriasis
- (2015) Peter C.M. van de Kerkhof DERMATOLOGIC CLINICS
- Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis
- (2015) Kristian Reich et al. EXPERIMENTAL DERMATOLOGY
- Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
- (2015) Jamie L. Harden et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis
- (2015) Safia Hussain et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14 , but Not with Loss-of-Function Mutations in IL36RN in European Patients
- (2015) Rotraut Mössner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris
- (2015) Dorottya M. Berki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis
- (2015) Wolf-Henning Boehncke et al. LANCET
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking
- (2014) Niovi Setta-Kaffetzi et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- Partial clinical response to anakinra in severe palmoplantar pustular psoriasis
- (2014) M. Tauber et al. BRITISH JOURNAL OF DERMATOLOGY
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis
- (2014) Trine Bertelsen et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
- (2014) Howard Sofen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CARD14 c.526G>C (p.Asp176His) Is a Significant Risk Factor for Generalized Pustular Psoriasis with Psoriasis Vulgaris in the Japanese Cohort
- (2014) Kazumitsu Sugiura et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
- (2014) Andrea Chiricozzi et al. PLoS One
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
- (2014) Andrea Saggini et al. Journal of Immunology Research
- Successful Treatment of Generalized Pustular Psoriasis With the Interleukin-1-Receptor Antagonist Anakinra: Lack of Correlation With IL1RN Mutations
- (2013) Manuelle Viguier ANNALS OF INTERNAL MEDICINE
- A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
- (2013) W.C. Ports et al. BRITISH JOURNAL OF DERMATOLOGY
- Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist?
- (2013) M. Tauber et al. BRITISH JOURNAL OF DERMATOLOGY
- Successful therapy with anakinra in a patient with generalized pustular psoriasis carryingIL36RNmutations
- (2013) U. Hüffmeier et al. BRITISH JOURNAL OF DERMATOLOGY
- Loss of IL36RN Function Does Not Confer Susceptibility to Psoriasis Vulgaris
- (2013) Dorottya M. Berki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment-Related Restoration of Langerhans Cell Migration in Psoriasis
- (2013) Frances L. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Transforming Growth Factor- Signaling in T Cells Promotes Stabilization of Atherosclerotic Plaques Through an Interleukin-17-Dependent Pathway
- (2013) A. Gistera et al. Science Translational Medicine
- PSORS2 Is Due to Mutations in CARD14
- (2012) Catherine T. Jordan et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Acitretin- and Tumor Necrosis Factor Inhibitor –Resistant Acrodermatitis Continua of Hallopeau Responsive to the Interleukin 1 Receptor Antagonist Anakinra
- (2012) Virginie Lutz ARCHIVES OF DERMATOLOGY
- Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
- (2012) Peter Schafer BIOCHEMICAL PHARMACOLOGY
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis
- (2012) C. Morales-Múnera et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-36 in psoriasis
- (2012) JE Towne et al. CURRENT OPINION IN PHARMACOLOGY
- Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis
- (2012) Sabina A Antoniu EXPERT OPINION ON INVESTIGATIONAL DRUGS
- IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
- (2012) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature
- (2012) SATVEER K. Mahil et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A Single Intradermal Injection of IFN-γ Induces an Inflammatory State in Both Non-Lesional Psoriatic and Healthy Skin
- (2012) Leanne M. Johnson-Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genetics of Psoriasis: Evidence for Epistatic Interaction between Skin Barrier Abnormalities and Immune Deviation
- (2012) Judith G.M. Bergboer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
- (2012) Kim A. Papp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
- (2012) Naresh Punwani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation
- (2012) Amanda Robinson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
- (2012) Kim Papp et al. LANCET
- Interleukin-17 contributes to cardiovascular diseases
- (2012) Hua-Sheng Ding et al. MOLECULAR BIOLOGY REPORTS
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
- (2012) Adam P. Gregory et al. NATURE
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
- (2012) Lam C Tsoi et al. NATURE GENETICS
- The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90
- (2012) Chenhui Wang et al. NATURE IMMUNOLOGY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases
- (2012) Jason S. Knight et al. Frontiers in Immunology
- Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
- (2011) Alexandros Onoufriadis et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Pharmacological and therapeutic effects of A3 adenosine receptor agonists
- (2011) Pnina Fishman et al. DRUG DISCOVERY TODAY
- Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis
- (2011) Marie-José Bijlmakers et al. HUMAN MOLECULAR GENETICS
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell death
- (2011) Ivan Scudiero et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional Pathways
- (2011) Francesca Capon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial
- (2011) M. David et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12
- (2011) Stefano M. Santini et al. PLoS One
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients
- (2011) T. Gambichler et al. REGULATORY PEPTIDES
- Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy
- (2010) S. Coimbra et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab: effective in a patient with severe recalcitrant generalized pustular psoriasis
- (2010) E. Daudén et al. BRITISH JOURNAL OF DERMATOLOGY
- Tuberculosis and anti-TNF treatment: experience of a central London hospital
- (2010) Satveer Mankia et al. CLINICAL RHEUMATOLOGY
- Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
- (2010) P. Lakatos et al. CURRENT DRUG TARGETS
- Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis
- (2010) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
- (2010) Josh Gregorio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effective Narrow-Band UVB Radiation Therapy Suppresses the IL-23/IL-17 Axis in Normalized Psoriasis Plaques
- (2010) Leanne M. Johnson-Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Langerhans Cell Mobilization Distinguishes between Early-Onset and Late-Onset Psoriasis
- (2010) Frances L. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis
- (2010) Judilyn Fuentes-Duculan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2
- (2010) Eva Ellinghaus et al. NATURE GENETICS
- A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
- (2010) Amy Strange et al. NATURE GENETICS
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA)
- (2010) Mayte Suárez-Fariñas et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
- (2010) Mona Gandhi et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Assessing Long-Term Drug Safety: Lessons (Re) Learned from Raptiva
- (2010) Nicole M. Seminara et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
- (2009) Yeonseok Chung et al. IMMUNITY
- Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases
- (2009) Leanne M. Johnson-Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
- (2009) Shinji Kagami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis
- (2009) Rafael de Cid et al. NATURE GENETICS
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
- (2009) Sara Trifari et al. NATURE IMMUNOLOGY
- Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
- (2009) Thomas Duhen et al. NATURE IMMUNOLOGY
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- β-Defensin-2 Protein Is a Serum Biomarker for Disease Activity in Psoriasis and Reaches Biologically Relevant Concentrations in Lesional Skin
- (2009) Patrick A. M. Jansen et al. PLoS One
- Antimicrobial peptides and self-DNA in autoimmune skin inflammation
- (2008) Michel Gilliet et al. CURRENT OPINION IN IMMUNOLOGY
- Identification of ZNF313 / RNF114 as a novel psoriasis susceptibility gene
- (2008) Francesca Capon et al. HUMAN MOLECULAR GENETICS
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Resident and “Inflammatory” Dendritic Cells in Human Skin
- (2008) Lisa C. Zaba et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Induction and effector functions of TH17 cells
- (2008) Estelle Bettelli et al. NATURE
- IFN-α Enhances Poly-IC Responses in Human Keratinocytes by Inducing Expression of Cytosolic Innate RNA Receptors: Relevance for Psoriasis
- (2007) Errol P. Prens et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now